MedicineBiology

HSP90 as a new therapeutic target for cancer therapy: the story unfolds

Alison Maloney, P. Workman

2002.1.1EXPERT OPINION ON BIOLOGICAL THERAPY

DOI: 10.1517/14712598.2.1.3

tlooto Summary

HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.

Abstract

Abstract is not available.

Citation format

MALONEY, Alison; WORKMAN, P. HSP90 as a new therapeutic target for cancer therapy: The story unfolds. EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2: 24–3.